Previous 10 | Next 10 |
JERUSALEM , Dec. 3, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company has entered into an Ordinary Shares Purchase Agreement for $10.0 million with Aspire Capital Fund, LLC ("Aspire Capital"), a Chicag...
JERUSALEM , Nov. 13, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate in the Jefferies London Healthcare Conference. Jefferies London Healthcare Conference Date: November 20-21, 2019 ...
Intec Pharma (NASDAQ: NTEC ): Q3 GAAP EPS of -$0.61 misses by $0.39 . More news on: Intec Pharma Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
JERUSALEM , Nov. 12, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and nine months ended September 30, 2019 . Highlights of the third quarter 2019 and recent weeks include: Presented two posters hi...
JERUSALEM , Sept. 25, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters highlighting data from the Company's Phase 3 clinical development program for the Accordion Pill ® Carbidopa/Levodopa (AP-CD/LD), were presented ye...
Gainers: Ovid Therapeutics (NASDAQ: OVID ) +27% . VolitionRx Limited (NYSEMKT: VNRX ) +24% . Cellcom Israel (NYSE: CEL ) +21% . Wheeler Real Estate Investment Trust (NASDAQ: WHLR ) +19% . Fresh Del Monte Produce (NYSE: FDP ) +16% . New Age Beverages Corporation (NASDAQ: NBEV ) ...
Plus Therapeutics (NASDAQ: PSTV ) +99% on BARDA payment . More news on: Plus Therapeutics, Inc., Avadel Pharmaceuticals plc, Arotech Corporation, Stocks on the move, Read more ...
The following slide deck was published by Intec Pharma Ltd. in conjunction with this Read more ...
September 16, 2019 Palm Beach, FL –September 16, 2019 – The global cancer therapy market looks like it will continue trend to continue its growth… worldwide. Cancer therapies are drugs that block the growth and proliferation of cancer, by interfering with spec...
JERUSALEM , Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters in support of the Company's Phase 3 clinical development program for the Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD), will be presented a...
News, Short Squeeze, Breakout and More Instantly...
Intec Pharma Ltd. Company Name:
NTEC Stock Symbol:
NASDAQ Market:
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows activity in M1 macrophages, natural killer cells, dendritic cells, Th1 CD4, and CD8 T cells NEW YORK, March 25, 2024 (...
“Fully Engaging The Human Immune System To Cure Disease,” Featuring CEO, Jeffrey Meckler Registration now open at INDPMarch2024.TribePublic.com NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ: INDP), a clinical stage biotech...